RelB Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of RelB monoclonal antibodies for various research applications. RelB monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RelB is a critical member of the NF-κB family of transcription factors, playing a significant role in immune response, inflammation, and cell survival. RelB functions are particularly important in the development and function of dendritic cells and are implicated in various diseases, including cancer and autoimmune disorders. Understanding RelB activity is essential for elucidating the mechanisms underlying these conditions and for developing targeted therapies. RelB monoclonal antibodies enable precise detection and analysis of protein expression patterns across different cell types and tissues. RelB monoclonal antibodies support detailed investigation of signaling pathways and molecular interactions in both normal and pathological states. Santa Cruz Biotechnology monoclonal antibodies contribute to advancing scientific knowledge by facilitating accurate and reliable research outcomes in immunology and cell biology studies.